0001752724-23-236145.txt : 20231025 0001752724-23-236145.hdr.sgml : 20231025 20231025083901 ACCESSION NUMBER: 0001752724-23-236145 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20231025 DATE AS OF CHANGE: 20231025 EFFECTIVENESS DATE: 20231025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIONEER SERIES TRUST II CENTRAL INDEX KEY: 0001265389 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-21460 FILM NUMBER: 231344118 BUSINESS ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-742-7825 MAIL ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 0001265389 S000010085 Pioneer AMT-Free Municipal Fund C000027935 Pioneer AMT-Free Municipal Fund: Class A PBMFX C000027937 Pioneer AMT-Free Municipal Fund: Class C MNBCX C000035677 Pioneer AMT-Free Municipal Fund: Class Y PBYMX N-CEN/A 1 primary_doc.xml X0404 N-CEN/A 0001752724-23-058082 LIVE 0001265389 XXXXXXXX 811-21460 false false false N-1A S000010085 C000027935 C000027937 C000035677 Pioneer Series Trust II 811-21460 0001265389 549300457JBM10EZI688 60 State Street Boston 02109 US-MA US 617-422-4947 Amundi Asset Management US, Inc. 60 State Street Boston 02109 617-422-4947 Records related to its functions as investment adviser and administrator. The Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records related to its functions as custodian and sub-administrator. Amundi Distributor US, Inc. 60 State Street Boston 02109 617-422-4947 Records related to its functions as principal underwriter. BNY Mellon Investment Servicing (U.S.) Inc. 4400 Computer Drive Westborough 01581 508-871-8500 Records related to its functions as shareholder servicing and transfer agent. Pioneer Series Trust II 60 State Street Boston 02109 617-422-4947 Records related to its functions as Registrant. N N N-1A 2 Y Thomas J. Perna N/A N John E. Baumgardner, Jr. N/A N Lorraine H. Monchak N/A N Craig C. MacKay 002008771 N Lisa M. Jones N/A Y Diane Durnin N/A N Kenneth J. Taubes N/A Y Marguerite A. Piret N/A N Benjamin M. Friedman N/A N Fred J. Ricciardi N/A N John Malone 002314031 60 State Street Boston 02109-1820 XXXXXX N N N N N N N Amundi Distributor US, Inc. 008-41256 000024497 549300OSI141GCUW7776 Y N Ernst & Young LLP 00042 N/A N N N N N N N Pioneer AMT-Free Municipal Fund S000010085 549300YL3O4P6CF3WW53 N 4 0 0 N/A N N N N N/A N/A N/A Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 22d-1 (17 CFR 270.22d-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4 (17 CFR 270.18f-4) Y Y N N Amundi Asset Management US, Inc. 801-08255 000107719 GVETZ2DEF39OCQ4SSX41 N BNY Mellon Investment Servicing (US) Inc. 084-01761 549300CFZQLI9QMJ1Z03 N N N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N BNY Mellon Investment Servicing (US) Inc. 549300CFZQLI9QMJ1Z03 N N N Amundi Asset Management US, Inc. GVETZ2DEF39OCQ4SSX41 Y N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N Y N Credit Agricole Securities (USA) Inc. 008-13753 000000190 549300WO2DKF0Q3YMV43 0.00000000 Amundi Distributor US, Inc. 008-41256 000024497 549300OSI141GCUW7776 0.00000000 0.00000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 131017583.00000000 UBS SECURITIES LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 34818988.00000000 HILLTOP SECURITIES INC. 008-45123 000006220 549300IXU82PMU6XZT45 44755351.00000000 BNY MELLON CAPITAL MARKETS, LLC 008-35255 000017454 VJW2DOOHGDT6PR0ZRO63 19783175.00000000 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 63655483.00000000 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 136225825.00000000 WELLS FARGO SECURITIES, LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 117156394.00000000 CitiGroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 51328739.00000000 BARCLAYS CAPITAL, INC. 008-41342 000019714 AC28XWWI3WIBK2824319 29120309.00000000 PERSHING LLC 008-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 221059131.00000000 891100099.00000000 N 1331868549.00000000 0.00000000 Committed 380000000.00000000 N N N N false false true false false true INTERNAL CONTROL RPT 2 g1aiii_pst_ii.htm

Report of Independent Registered Public Accounting Firm 

  

To the Shareholders and Board of Trustees of 

Pioneer Series Trust II: 

  

In planning and performing our audit of the financial statements of Pioneer AMT-Free Municipal Fund (the “Fund”) (one of the funds constituting Pioneer Series Trust II (the “Trust”)) as of and for the year ended December 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Trust’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Trust’s internal control over financial reporting. Accordingly, we express no such opinion.   


The management of the Trust is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.  

  

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Trust’s annual or interim financial statements will not be prevented or detected on a timely basis.  

  

Our consideration of the Trust’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Trust’s internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of December 31, 2022. 

  

This report is intended solely for the information and use of management and the Board of Trustees of  

Pioneer Series Trust II, and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

  

  

/s/ ERNST & YOUNG LLP 

   

  

Boston, Massachusetts 

March 1, 2023 

  

OTHER REQUIRED INFO 3 explanatory_note_2023.htm

Form: N-CEN/A

Explanation:

This amendment is being filed to address incorrect or omitted responses from the original submission.